Showing results (191-200 of 209) with videos related to

Sort By:
Pageof 21
Vaccines|July 27, 2024
Capturing the Value of Vaccination within Health Technology Assessment and Health Economics-Practical Considerations for Expanding Valuation by Including Key ConceptsEliana Biundo, Mariia Dronova, Annie Chicoye, et al.
Supportive Care in Cancer : Official Journal of the Multinational Association of Supportive Care in Cancer|May 24, 2024
A population-based analysis of the management of symptoms of depression among patients with stage IV non-small cell lung cancer (NSCLC) in Ontario, CanadaVivian S Tan, Michael C Tjong, Wing C Chan, et al.
Current Oncology (Toronto, Ont.)|March 28, 2023
Pain and Interventions in Stage IV Non-Small Cell Lung Cancer: A Province-Wide AnalysisVivian S Tan, Michael C Tjong, Wing C Chan, et al.
Clinical and Vaccine Immunology : CVI|February 10, 2006
Recognition of stage-specific mycobacterial antigens differentiates between acute and latent infections with Mycobacterium tuberculosisAbebech Demissie, Eliane M S Leyten, Markos Abebe, et al.
Lung Cancer (Amsterdam, Netherlands)|March 15, 2021
Impact of EGFR mutation on outcomes following SRS for brain metastases in non-small cell lung cancerFabio Y Moraes, Alireza Mansouri, Archya Dasgupta, et al.
The Journal of Experimental Medicine|November 11, 2009
Two loci control tuberculin skin test reactivity in an area hyperendemic for tuberculosisAurelie Cobat, Caroline J Gallant, Leah Simkin, et al.
Journal of Thoracic Disease|September 11, 2023
Recommended first-line management of asymptomatic brain metastases from EGFR mutant and ALK positive non-small cell lung cancer varies significantly according to specialty: an international survey of clinical practiceChin Heng Fong, Nicholas Meti, Timothy Kruser, et al.
Advances in Radiation Oncology|June 13, 2020
Neurological Death is Common in Patients With EGFR Mutant Non-Small Cell Lung Cancer Diagnosed With Brain MetastasesMatthew Ramotar, Sierra Barnes, Fabio Moraes, et al.
Journal of Clinical Epidemiology|August 6, 2010
The Patient-Reported Outcomes Measurement Information System (PROMIS) developed and tested its first wave of adult self-reported health outcome item banks: 2005-2008David Cella, William Riley, Arthur Stone, et al.
Clinical Lung Cancer|January 24, 2017
Real-World EQ5D Health Utility Scores for Patients With Metastatic Lung Cancer by Molecular Alteration and Response to TherapyCatherine Labbé, Yvonne Leung, João Gabriel Silva Lemes, et al.
Pageof 21